Prevent Blindness has designated November 18 to 24, 2024, as the 5th annual Thyroid Eye Disease (TED) Awareness Week. The ...

An international, Phase III clinical trial led by investigators at Mass General Brigham could improve the treatment of a rare ...

2 Top Growth Stocks to Buy on the Dip was originally published by The Motley Fool ...

HYDERABAD: IT and Industries Minister D Sridhar Babu on Thursday announced that the Congress government has secured ...

Residents in more rural communities of New Hampshire will soon have access to ultra-high-capacity, high-speed broadband technology, thanks to the launch of Trailrunner Broadband's upgraded high-speed ...

The Price to Earnings (P/E) ratio, a key valuation measure, is calculated by dividing the stock's most recent closing price by the sum of the diluted earnings per share from continuing operations ...

Breakthrough T1D, formerly JDRF, the leading global type 1 diabetes (T1D) research and advocacy organization, today announced ...

Regulators are reviewing what could become a multi-billion-dollar drug.

Shares of biopharma companies levered to COVID-19 vaccines tumbled on Thursday after President-elect Donald Trump picked ...

Merck is playing defense against Summit Therapeutics with a $3.3 billion licensing deal announced Thursday for a cancer drug.